N. Chavannes (Rotterdam, Netherlands), M. Roman Rodriguez (Palma De Mallorca, Spain)
Prevalence of undiagnosed COPD: systematic review and meta-analysis R. Halbert, J. Natoli, A. Gano, D. Tinkelman (Los Angeles, CA, Beverly Hills, CA, Denver, CO, United States Of America)
| |
Validation study of pulse oximeters K. Miyamoto (Sapporo, Japan)
| |
Effect of salmeterol/fluticasone propionate versus tiotropium bromide on withdrawal rate, health status, lung function and mortality: INSPIRE (investigating new standards for prophylaxis in reduction of exacerbations) study R. Stockley, P. Calverley, T. Seemungal, G. Hagan, J. Wedzicha (Birmingham, Liverpool, London, United Kingdom; Mount Hope, Trinidad And Tobago)
| |
Defining airways obstruction – fixed ratio versus lower limit of normal B. Lamprecht, L. Schirnhofer, B. Kaiser, M. Studnicka (Salzburg, Austria)
| |
Integrated disease management improves long-term quality of life in primary care COPD patients N. Chavannes, M. Grijsen, M. Akker van den, H. Schepers, M. Nijdam, B. Tiep, J. Muris (Rotterdam, Maastricht, Bocholtz, Netherlands; Irwindale, United States Of America)
| |
Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care F. H. Rutten, J. W. J. Lammers, M. J. M. Cramer, N. P. A. Zuithoff, A. W. Hoes (Utrecht, Netherlands)
| |
Monitoring of COPD. A review of current guidelines‘ recommendations L. van den Bemt, T. Schermer, I. Smeele, E. Bisschoff, A. Jacobs, R. Grol, C. van Weel (Nijmegen, Etten-Leur, Netherlands)
| |
COPD health forecasting and anticipatory care: a patient perspective C. Bryden, P. Marno, P. Sachon, S. McIver, T. Laing-Morton (Exeter, Birmingham, United Kingdom)
| |